Remimazolam Tosilate for Injection

DRUG4 trials

Sponsors

Jiangsu HengRui Medicine Co., Ltd.

Conditions

Gastroscopic and Colonoscopic SedationGeneral Anesthesia and Bronchoscopy SedationOperative Sedation of Adolescent PatientsOperative Sedation of PediatricSedation in Non-intubated Diagnostic and Therapeutic Procedures

Phase 2

A Trial of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients

RecruitingNCT07036419

Jiangsu HengRui Medicine Co., Ltd.Operative Sedation of Adolescent Patients, Operative Sedation of Pediatric

Start: 2025-07-10End: 2026-05-01Target: 240Updated: 2026-02-18

Phase 4

A Study of Remimazolam Tosilate for Sedation in Non-intubated Diagnostic and Therapeutic Procedures

Jiangsu HengRui Medicine Co., Ltd.Sedation in Non-intubated Diagnostic and Therapeutic Procedures

Start: 2024-01-31End: 2024-03-31Target: 240Updated: 2024-01-22

Unknown Phase

A Non-interventional Study of Remazolam Methyl Benzene Sulfonic Acid for Injection in Real-world Clinical Practice

CompletedNCT05254366

Jiangsu HengRui Medicine Co., Ltd.Gastroscopic and Colonoscopic Sedation

Start: 2022-01-30End: 2023-02-08Updated: 2026-01-05

A Non-intervention Fiberoptic Bronchoscopy Study of Remazolam Toluene Sulfonate for Injection Under General Anesthesia and Fiberoptic Bronchoscopy

CompletedNCT05549791

Jiangsu HengRui Medicine Co., Ltd.General Anesthesia and Bronchoscopy Sedation

Start: 2022-08-18End: 2024-06-21Updated: 2026-01-05